Help us vanquish cancer
Donate online
Other ways to give
You can also donate by phone (514 343-6111, poste 6141), in person, by email (chantal.mallette@umontreal.ca) or by filling out this donation form and mailing it to IRIC.
One in two Canadians is expected to develop cancer in their lifetime.
One in four Canadians is expected to die from this disease.
The leading cause of death in the country, cancer is a social issue that affects us all. That’s why IRIC needs you to help advance research leading to the discovery of new therapies. By making a donation to IRIC, you are directly contributing to funding research that helps to accelerate the fight against cancer.
Université de Montréal launches its major philanthropic campaign. Help us meet the great challenges of our time by supporting IRIC.
Contact the philanthropy team:
Chantal Malette
Senior Philanthropy and Development Advisor
chantal.mallette@umontreal.ca
514-343-6111, ext. 6141
Steve Ntambwe
Philanthropy, Development Advisor
steve.ntambwe@umontreal.ca
514 343-6111, ext. 27938
On April 10, over 250 guests gathered for IRIC’s Gala Audace 2024. Thanks to the generosity of donors and guests, $750 000 was raised. Since 2014, more than $8 million has been raised through the Gala Audace, helping to perpetuate IRIC’s fundamental research and perfect cancer therapies.
Since 2019, with generous support from the Richard and Edith Strauss Foundation, researchers and their teams have been able to further investigate pediatric leukemia and acute myeloid leukemia (AML), pushing the boundaries of science on these types of cancer.
Located in the heart of the Université de Montréal, IRIC is a unique research centre in Canada. The Institute groups together, under one roof, a team of Investigators from around the world, a unique university program to train the next generation of scientists and a commercialization hub that accelerates the discovery of novel therapies.
For the past 20 years, your donations have enabled us to reinvent research and to make spectacular advances to shed light on the mechanisms of cancer. Your generosity has resulted in the recruitment of 35 distinguished Investigators, the awarding of over 250 scholarships to the top graduate students, the funding of 21 major innovative projects and the acquisition of cutting-edge equipment, including one device for proteomics and one device for high-throughput screening.
The number of new cancer cases increases each year, mainly because of the aging population. Along with the disastrous consequences for patients and their families, cancer is an enormous burden on society, for its detrimental impact on both the healthcare system and the national economy. In order to reverse that trend, more and more money must be invested to support research. The financing obtained by the major funding organizations is not enough to support research. As a result, developing more effective and better adapted cancer therapies requires a collective effort.
Investigators use a wide variety of approaches and experimental models and they pool their expertise to create a greater understanding of the mechanisms of cancer. They also strive to develop new diagnostic tools and to discover new therapeutic solutions benefiting patients.
Several research projects funded by our donors are currently in the clinical trial phase in hospitals. One of them, the discovery of the UM171 molecule by Investigator Anne Marinier, Dr. Guy Sauvageau and their teams, has already enabled blood cancer patients to have access to a safe stem cell transplant. The work carried out by Dr. Claude Perreault in immuno-oncology also paves the way for the development of a therapeutic vaccine against leukemia and other types of cancer. Many other novel projects need your support.
To learn more about IRIC’s projects and funding needs, please contact Chantal Mallette, Senior Development Advisor, at 514-343-6111, ext 6141 or by email: chantal.mallette@umontreal.ca.
IRIC wants to create an incubator to foster the excellence of the next generation of scientists. By enriching its offering of scholarships and by properly supporting the training of its young Investigators, the Institute aims to improve their chances for success. And your donations can make that happen.
We must innovate right from the fundamental research step. That said, the types of projects with great potential for new drug discovery are often high-risk and therefore rarely secure funding from traditional public funding organizations. Yet these projects have the capacity to revolutionize the cancer research landscape.
Donate online
Other ways to give
You can also donate by phone (514 343-6111, poste 6141), in person, by email (chantal.mallette@umontreal.ca) or by filling out this donation form and mailing it to IRIC.
Your donations contribute to building a cancer-free future. Along with actively funding current research projects, your donations also make it possible for IRIC to initiate promising strategic projects, recruit distinguished Investigators, award scholarships to the top research students and acquire cutting-edge equipment : the proteomics platform (Orbitrap Ascend Tribrid from Thermo Scientific) and the new 400 MHz NMR at the Biophysics platform.
Would you like to get involved, become an ambassador for cancer research and organize an event to benefit IRIC?
We are very grateful for your support and the generosity of your initiatives. Please contact us for more information.
IRIC wishes to highlight the great generosity of the Katelyn Bedard Bone Marrow Association, which has been supporting the work of Dr. Claude Perreault’s team for 15 years. In 2022, a donation of $10,000 was made and to date, $90,000 has been donated to the Perreault laboratory to further research into hematopoietic cell transplantation and leukemia treatment.
In early 2020, IRIC created its brand new “Fonds vaccin thérapeutique contre le cancer”, a fund initiated by Dr. Robert Patenaude with a personal contribution of $25,000. The objective was to support the scientists involved in the project, namely the team led by Dr. Claude Perreault, in collaboration with the teams led by Sébastien Lemieux and Pierre Thibault, who work tirelessly to change the life of people affected by cancer.
Because the next generation of scientists means so much to them, IRIC’s Chief Executive Officer, Mr. Michel Bouvier, and his partner, Ms. Muriel Aubry, retired Professor and Director of the Department of Biochemistry and Molecular Medicine at the Université de Montréal, are pleased to announce the creation of two endowed funds to support students.
IRIC is very grateful to announce the philanthropic support of donor Pierre Sauvé, Engr., a 1966 graduate of Polytechnique Montréal. Extensively involved with the Université de Montréal over the past few years, particularly with l’Association des diplômés, Mr. Sauvé has shown tremendous generosity towards our academic institution on many occasions.
For the past 15 years, many people, foundations and companies have generously contributed to the success of the Institute and the pursuit of its mission. The entire IRIC community wholeheartedly thanks them for their support.
